SUMMARY A patient is described with acute dysautonomia associated with Hodgkin's disease. Testing of cardiovascular reflex control showed that this patient had a rare manifestation of autonomic cardiovascular neuropathy, namely intact parasympathetic heart rate control in combination with a sympathetic postganglionic lesion affecting the control of the vascular tree.
cardiovascular lesion has never been reported to our treated with 100 jig fludrocortisone daily with slight improvement. knowledge. In this case-report we describe a patient On re-examination in June 1984 a dilated left pupil and with acute autonomic dysfunction, associated with diminished right sided Achilles tendon reflex were still Hodgkin's disease and, as an especially unusual fea-present. Instillation of 0-125% pilocarpine hydrochloride ture, severe orthostatic hypotension with intact vagal produced miosis of the left pupil, but had no effect on the heart rate control.
diameter of the normal right pupil. The (table) .4' Supersensitivity to phenylephrine, no release of noradrenaline after a high dose of tyramine and no pilomotor responses after intradermal acetylcholine (table) imply a lesion in the postganglionic sympathetic nerves.1 245 Cardiac vagal denervation is common in acute dysautonomia and in diabetic autonomic neuropathy as well, whereas overt sympathetic circulatory impairment appears to be rare. ' 24 12 The form of autonomic neuropathy in this patient with the unusual combination of intact parasympathetic HR control and a sympathetic lesion affecting the control of the vascular tree may be interpreted as the mirror image of the common pattern.
Severe orthostatic hypotension persisted; nevertheless the much more pronounced increment in HR after 1 minute standing at the second examination (75 BPM vs. 38 BPM), the partial recovery of pilomotor function and perhaps the increase in supine catecholamines suggest improvement of sympathetic cardiovascular control. The combination of hypoadrenergic orthostatic hypotension (fig, table) 45 and a marked postural tachycardia has to our knowledge not been described before.
with Hodgkin's disease.
Letters recommended that, in elderly patients at least, it would be prudent to perform an ECG prior to starting carbamazepine therapy.3 l All nine cases described so far, have been elderly and only one patient has had epilepsy. No fatalities have been reported, and in the two detailed post-mortem studies on sudden death in epileptics,8 9 only one was taking carbamazepine, but not in the therapeutic dosage. 8 We suggest, however, that carbamazepine was responsible both for the syncopal attacks and the death of our young epileptic probably by causing ventricular asystole.
The lesson to be drawn would seem to be that any patient on carbamazepine, for whatever reason, who complains of syncope or a change in seizure type, should be admitted for investigation of this atrio-ventricular conduction system.
The differentiation of cardiac and epileptic loss of consciousness can often be difficult and the temptation to increase the dose of carbamazepine in an epileptic who complains of loss ofconsciousness should be resisted until assessment of their cardiovascular status is complete. If in doubt, it is probably best to stop the drug and substitute an alternative. It may be prudent to perform an ECG in the elderly, before commencing treatment with carbamazepine but, in the absence of further data on death related to the drug, no further precautions can be justified.
